Latest Licensing Agreements News

Page 1 of 23
Temas Resources has secured an estimated C$52,876 Stage 1 contract to test its Regenerative Chloride Leach technology on samples from an unnamed Québec mineral company. The nearby project could offer a regional processing opportunity, while a new governance appointment reshapes the board.
Victor Sage
Victor Sage
19 Nov 2026
Anson Resources says its proprietary pre-treatment process removed iron to undetectable levels from a third-party lithium brine in a single pass, while retaining lithium within its stated tolerance. The company is now discussing potential technology sales, although no transaction or financial benefit has been secured.
Maxwell Dee
Maxwell Dee
10 Nov 2026
Nine Entertainment has maintained its forecast for revenue and EBITDA growth in FY27, while lifting its expected annualised cost savings target to at least A$180 million. Outdoor, Stan and digital publishing are carrying more of the group’s earnings, although Total Television revenue remains under pressure and shareholder support for executive remuneration was less emphatic.
Victor Sage
Victor Sage
6 Nov 2026
Battery Age Minerals advanced its Bleiberg germanium permits and expanded Falcon Lake to about 60 km², but its cash position now covers an estimated 1.34 quarters of funding. Initial Apex fieldwork also failed to confirm the remote-sensing anomalies that had defined the Utah targets.
Victor Sage
Victor Sage
30 Oct 2026
Dimerix has more than doubled its cash balance after an Everest Medicines licensing payment and a drawdown from a secured funding facility. The ASX-listed biotech is also advancing its fully recruited Phase 3 trial while preparing a second kidney drug for Phase 2 testing.
Ada Torres
Ada Torres
29 Oct 2026
Laserbond delivered strong FY26 growth despite higher tungsten costs and soft mining demand, while securing a second Komatsu licensing agreement and a new international collaboration with Metal 7. The company is now positioning lower-tungsten products, new coatings and expanded capacity for a much larger market.
Victor Sage
Victor Sage
22 Oct 2026
ION Video has reported a $4.52 million FY2026 loss and a $3.21 million operating cash drain, even as a post-year-end $4.25 million placement lifted its balance sheet. Auditors have preserved their opinion but flagged material uncertainty over the company’s ability to continue as a going concern.
Sophie Babbage
Sophie Babbage
30 Sept 2026
Radiopharm Theranostics reported a A$56.3 million comprehensive loss for fiscal 2026, with operating cash outflows rising to A$52.8 million and cash falling to A$4.1 million. The company says further funding is required, while auditors flag a material uncertainty over its ability to continue as a going concern.
Victor Sage
Victor Sage
30 Sept 2026
Vulcan Energy has started commercial-scale production in Germany of VULSORB, the proprietary adsorbent at the centre of its planned direct lithium extraction process. The material will supply first-fill volumes for Project Lionheart, although lithium production remains targeted for the second half of 2028.
Victor Sage
Victor Sage
21 Sept 2026
Vectus Biosystems swung to a $1.56 million FY2026 profit, but the result was driven largely by the sale of its VB4-P5 compound for XORTX shares and warrants rather than recurring operations. The company is now directing its resources towards VB0004 while its auditor flags material uncertainty over ongoing funding.
Ada Torres
Ada Torres
18 Sept 2026
Ionic Rare Earths is pushing toward commercial magnet recycling in Belfast and the United States, but its FY2026 report flags a material uncertainty over its ability to continue as a going concern. The company reported a larger A$14.9 million loss and A$13.9 million in operating cash outflows, despite government support and new strategic partnerships.
Victor Sage
Victor Sage
17 Sept 2026
ION Video has secured an oversubscribed $4.25 million placement to fund independent trials of its video technology, with directors and management committing a further $1.2 million subject to shareholder approval. The capital will be used to test whether ION’s architecture can deliver measurable technical and financial benefits in real operating environments.
Sophie Babbage
Sophie Babbage
16 Sept 2026

Browse the archive

Full archive